OrbiMed Advisors LLC's Form 4 filing
Damora Therapeutics, Inc. (DMRA) · filed Apr 12, 2023
- Accession no.
- 0000947871-23-000452
- Filed
- Apr 12, 2023, 6:44 PM ET
- Trade date
- Apr 10-12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions. Open-market sales total $121.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | Common Stock | SSaleDisposed | −2,584 | $1.79 | −$4,625.36 | 185,910 | Indirect | |
| Apr 10, 2023 | Common Stock | SSaleDisposed | −13,899 | $1.79 | −$24,879.21 | 1,000,187 | Indirect | |
| Apr 10, 2023 | Common Stock | SSaleDisposed | −34,745 | $1.79 | −$62,193.55 | 2,500,582 | Indirect | |
| Apr 11, 2023 | Common Stock | SSaleDisposed | −703 | $1.82 | −$1,279.46 | 183,326 | Indirect | |
| Apr 11, 2023 | Common Stock | SSaleDisposed | −3,784 | $1.82 | −$6,886.88 | 986,288 | Indirect | |
| Apr 11, 2023 | Common Stock | SSaleDisposed | −9,459 | $1.82 | −$17,215.38 | 2,465,837 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −119 | $1.81 | −$215.39 | 183,207 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −641 | $1.81 | −$1,160.21 | 985,647 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −1,603 | $1.81 | −$2,901.43 | 2,464,234 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.